Transcatheter Pulmonary Valve Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, France, China - Size and Forecast 2024-2028

Transcatheter Pulmonary Valve Market Size 2024-2028

The transcatheter pulmonary valve market size is forecast to increase by USD 46.7 million at a CAGR of 5.6% between 2023 and 2028.

• The market is experiencing significant growth due to the rising incidence of cardiac diseases and favorable reimbursement policies. The use of transcatheter pulmonary valves, which include annuloplasty rings and valves delivered via catheters, is increasing as they offer less invasive alternatives to surgical procedures. However, the shortage of cardiologists and the complexity of these procedures pose challenges to market growth. Analytics indicate that the market is expected to continue its upward trajectory, driven by technological advancements and increasing demand for minimally invasive heart valve replacement options. The market offers numerous opportunities for stakeholders, including manufacturers, healthcare providers, and patients.

What will be the Size of the Transcatheter Pulmonary Valve Market During the Forecast Period?

Request Free Sample

• The market encompasses innovative treatment options for various cardiovascular diseases, particularly congenital heart diseases such as pulmonary stenosis and pulmonary regurgitation. Imaging techniques like CT angiography and 3D echocardiography facilitate procedural planning and device selection. TPV operations offer less invasive alternatives to open-heart surgery, addressing the growing demand for minimally invasive procedures. Cardiovascular medicine continues to evolve, with a focus on improving patient outcomes and reducing healthcare spending. Patient awareness programs play a crucial role in increasing the understanding of heart health and the benefits of TPV procedures. Delivery catheters and self-expanding heart valves are key components of TPV technology, offering flexibility and precision during the intervention.

• Balloon-expandable transcatheter valves and synthetic heart valves are essential solutions for addressing cardiac abnormalities in both adult and pediatric populations. The market's growth is driven by the increasing prevalence of cardiovascular diseases and the ongoing development of advanced technologies to improve patient care. Innovative TPV solutions contribute significantly to the healthcare industry's efforts to enhance the quality of life for those living with heart conditions. The market is experiencing growth as advancements in medical technologies improve treatment options for patients with congenital heart defects.

How is this Transcatheter Pulmonary Valve Industry segmented and which is the largest segment?

The industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• Technology
  • Balloon-expanded
  • Self-expanded
• Geography
  • North America
    • US
  • Europe
    • Germany
    • UK
    • France
  • Asia
    • China
  • Rest of World (ROW)

By Technology Insights

• The balloon-expanded segment is estimated to witness significant growth during the forecast period.

The market is experiencing notable growth due to the increasing prevalence of congenital heart diseases and cardiovascular diseases. Imaging techniques, such as CT angiography and 3D echocardiography, facilitate procedural planning and device selection. TPV operations offer less invasive alternatives to open-heart surgery for patients with pulmonary stenosis, pulmonary regurgitation, and other cardiac abnormalities. The market encompasses various types of valves, including self-expanding and balloon-expandable transcatheter valves. Synthetic heart valves are gaining popularity due to their durability and effectiveness. Patient awareness programs are crucial in increasing patient engagement and driving demand for innovative treatment options. The balloon-expanded segment is expected to dominate the market due to its faster procedure times, simpler recuperation, and suitability for patients unable to undergo surgery.

Healthcare spending on heart procedures continues to rise, providing opportunities for market growth. Clinical evidence and regulatory approval are crucial in ensuring the success of TPV technologies, including annuloplasty rings, mitral and tricuspid valve technologies, and bicuspid aortic valves. Technology trends, such as AI and start-ups, are transforming the heart valve industry, offering new clinical research and treatment options for aortic regurgitation, rheumatic heart disease, and aortic stenosis.

Get a glance at the Transcatheter Pulmonary Valve Industry report of share of various segments Request Free Sample

The balloon-expanded segment was valued at USD 85.40 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

• North America is estimated to contribute 43% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

The North American market is experiencing significant growth due to the advanced cardiovascular medicine landscape and increasing patient awareness programs. This market expansion is driven by the rising prevalence of cardiovascular diseases, such as pulmonary stenosis and regurgitation, particularly In the congenital heart disease (CHD) population. CHD is a leading cause of birth defect-related infant illness and death In the US, affecting approximately 1% of births or over 40,000 babies annually, according to the Centers for Disease Control and Prevention (CDC). Innovative treatment options, including self-expanding and balloon-expandable transcatheter valves, are gaining popularity as alternatives to open-heart surgery. Imaging techniques like CT angiography and 3D echocardiography aid in procedural planning and device selection.

The market's growth is further fueled by the increasing healthcare expenditure and the need for minimally invasive procedures. Key technology trends include the integration of artificial intelligence and the emergence of start-ups and clinical research In the heart valve industry.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise In the adoption of Transcatheter Pulmonary Valve Industry?

The rising incidence of cardiac diseases is the key driver of the market.

• The market is experiencing significant growth due to the increasing prevalence of heart diseases, particularly In the aging population. According to the National Institutes of Health (NIH), approximately 10% of individuals aged 75 years and above in developed and developing countries, including the US, Germany, Australia, Canada, India, and Brazil, suffer from degenerative heart valve abnormalities such as severe aortic stenosis and mitral and tricuspid regurgitation. This trend is expected to continue as the global population ages, leading to a higher incidence of heart diseases. Imaging techniques, including CT angiography and 3D echocardiography, play a crucial role in procedural planning and device selection for Transcatheter Pulmonary Valve (TPV) operations.
• These minimally invasive procedures are increasingly preferred over open-heart surgery for treating cardiovascular diseases, such as pulmonary stenosis and pulmonary regurgitation, In the pediatric and adult population. Innovative treatment options, such as self-expanding heart valves and balloon-expandable transcatheter valves, are gaining popularity due to their effectiveness in addressing cardiac abnormalities. Synthetic heart valves, including those made from bovine pericardium or porcine bioprostheses, are also widely used. Patient awareness programs focusing on heart health and early detection of heart diseases are essential to reduce healthcare spending on surgical procedures and improve patient care pathways. Clinical evidence and regulatory approval for TPVs continue to grow, with advancements in mitral valve technologies, tricuspid valve technologies, annuloplasty rings, and patient engagement strategies.

What are the market trends shaping the Transcatheter Pulmonary Valve Industry?

Favorable reimbursement policies is the upcoming market trend.

• The market has experienced significant growth due to advancements in imaging techniques, such as CT angiography and 3D echocardiography, enabling more accurate procedural planning and device selection. These innovations are particularly beneficial for the treatment of congenital heart diseases, including pulmonary stenosis and regurgitation. Cardiovascular medicine continues to evolve, with patient awareness programs playing a crucial role in increasing heart health awareness and driving demand for cardiovascular disease treatment. TPV operations have emerged as a breakthrough therapy for patients with cardiac abnormalities, offering less invasive alternatives to open-heart surgery. Self-expanding heart valves and balloon-expandable transcatheter valves have gained popularity, with the latter experiencing significant market traction.
• Synthetic heart valves, including those for the mitral and tricuspid valves, are also seeing increased use. Clinical evidence and regulatory approval are key drivers In the market, with a focus on improving patient care pathways and technology trends. Artificial intelligence, start-ups, and clinical research are shaping the future of the heart valve industry. Annuloplasty rings and patient engagement are essential components of the patient care pathway, with a growing emphasis on improving patient outcomes and reducing healthcare expenditure. Cardiovascular diseases, including pulmonary valve diseases, aortic regurgitation, and bicuspid aortic valves, continue to pose a significant healthcare challenge. The market for transcatheter pulmonary valves is expected to grow as innovative treatment options become more accessible and affordable, with the potential to revolutionize heart procedures for the pediatric population and beyond.

What challenges does the Transcatheter Pulmonary Valve Industry face during its growth?

A shortage of cardiologists is a key challenge affecting the industry growth.

• In the realm of cardiovascular medicine, imaging techniques such as CT angiography and 3D echocardiography have revolutionized procedural planning for Transcatheter Pulmonary Valve (TPV) operations. These advanced imaging methods enable precise device selection for the treatment of various cardiac abnormalities, including pulmonary stenosis and pulmonary regurgitation, in both adult and pediatric populations. TPV procedures offer innovative treatment options for patients with congenital heart diseases and cardiovascular diseases, such as rheumatic heart disease, aortic regurgitation, bicuspid aortic valves, and mitral and tricuspid valve diseases. The market for these synthetic heart valves is experiencing significant growth due to increasing healthcare spending, patient awareness programs, and clinical research.
• Delivery catheters, self-expanding heart valves, and balloon-expandable transcatheter valves are some of the technology trends In the heart valve industry. Clinical evidence and regulatory approval are crucial factors driving the adoption of these innovative treatments. Patient care pathways and technology advancements, such as annuloplasty rings and patient engagement tools, are essential components of the patient journey. Artificial intelligence and start-ups are also making significant strides In the field of cardiovascular diseases, offering new possibilities for diagnosis and treatment. The heart health awareness movement is increasing the demand for heart procedures, with TPV operations becoming increasingly popular due to their minimally invasive nature and shorter recovery times compared to open-heart surgery.

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence In the industry.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Abbott Laboratories
• Artivion Inc.
• Boston Scientific Corp.
• Braile Biomedica
• Colibri Heart Valve LLC
• Edwards Lifesciences Corp.
• JenaValve Technology Inc.
• Medtronic PLC
• Venus Medtech Hangzhou Inc.
• Xeltis B.V.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

The market represents a significant segment within the cardiovascular medicine industry, focusing on the development and implementation of innovative treatment options for various cardiovascular diseases. This market encompasses imaging techniques such as CT angiography and 3D echocardiography, which play a crucial role in procedural planning and device selection. Imaging techniques provide essential information for cardiologists and interventionalists to assess the severity of cardiovascular abnormalities, including congenital heart diseases like pulmonary stenosis and pulmonary regurgitation. These conditions, among others, necessitate interventions such as transcatheter pulmonary valve replacement (TPV) operations. Traditional surgical procedures, such as open-heart surgery, have long been the primary treatment option for heart valve diseases.

However, the advent of transcatheter valve technologies has revolutionized the field, offering less invasive alternatives for patients. Self-expanding and balloon-expandable transcatheter valves, as well as synthetic heart valves, have emerged as viable options for treating various cardiac abnormalities In the pediatric and adult populations. Heart health awareness and the increasing prevalence of cardiovascular diseases have led to a rise in healthcare spending on heart procedures. The market for transcatheter pulmonary valves is expected to grow as patient engagement programs and clinical research continue to demonstrate the benefits of these innovative treatment options. Regulatory approval processes and clinical evidence are critical components of the market.

Furthermore, advancements in technology trends, such as AI and start-ups, are also contributing to the development of new and improved heart valve technologies. Annuloplasty rings and mitral and tricuspid valve technologies are just a few examples of the ongoing innovation in this field. The market is characterized by a diverse range of conditions requiring treatment, including rheumatic heart disease, aortic regurgitation, and bicuspid aortic valves. Aortic stenosis and pulmonary regurgitation are among the most common heart valve diseases addressed by transcatheter pulmonary valve technologies.

Request Free Sample

What are the Key Data Covered in this Transcatheter Pulmonary Valve Market Research and Growth Report?

• CAGR of the Transcatheter Pulmonary Valve industry during the forecast period
• Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
• Accurate predictions about upcoming growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the transcatheter pulmonary valve market growth of industry companies

We can help! Our analysts can customize this transcatheter pulmonary valve market research report to meet your requirements.

Get in touch